Youlian Zhou

3.1k total citations
55 papers, 1.9k citations indexed

About

Youlian Zhou is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Youlian Zhou has authored 55 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 20 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Youlian Zhou's work include Gut microbiota and health (35 papers), Clostridium difficile and Clostridium perfringens research (19 papers) and Inflammatory Bowel Disease (13 papers). Youlian Zhou is often cited by papers focused on Gut microbiota and health (35 papers), Clostridium difficile and Clostridium perfringens research (19 papers) and Inflammatory Bowel Disease (13 papers). Youlian Zhou collaborates with scholars based in China, United States and Sweden. Youlian Zhou's co-authors include Yuqiang Nie, Ye Chen, Haoming Xu, Hailan Zhao, Jing Xu, Yongjian Zhou, Le Liu, Jie He, Hanchang He and Qianyun Lin and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Youlian Zhou

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youlian Zhou China 24 1.4k 393 358 305 303 55 1.9k
Alba Santiago Spain 14 1.2k 0.9× 394 1.0× 342 1.0× 291 1.0× 370 1.2× 18 1.7k
Aonghus Lavelle Ireland 13 1.5k 1.1× 408 1.0× 438 1.2× 290 1.0× 225 0.7× 29 2.1k
Zhaohua Shen China 19 1.2k 0.9× 268 0.7× 372 1.0× 237 0.8× 259 0.9× 31 1.7k
Léon Zheng United States 12 2.0k 1.4× 356 0.9× 320 0.9× 542 1.8× 260 0.9× 19 2.7k
Josephine Ni United States 8 1.0k 0.7× 307 0.8× 548 1.5× 162 0.5× 370 1.2× 14 1.6k
Encarna Varela Spain 21 1.3k 1.0× 494 1.3× 617 1.7× 308 1.0× 394 1.3× 39 2.3k
Hannah Fehlner-Peach United States 8 1.4k 1.0× 386 1.0× 362 1.0× 491 1.6× 367 1.2× 8 2.2k
Edda Russo Italy 23 1.2k 0.9× 215 0.5× 283 0.8× 424 1.4× 397 1.3× 60 2.1k
Roberto Ferrarese Italy 19 880 0.6× 279 0.7× 224 0.6× 219 0.7× 237 0.8× 36 1.6k
Horace R. Williams United Kingdom 25 1.3k 0.9× 665 1.7× 339 0.9× 272 0.9× 635 2.1× 75 2.3k

Countries citing papers authored by Youlian Zhou

Since Specialization
Citations

This map shows the geographic impact of Youlian Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youlian Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youlian Zhou more than expected).

Fields of papers citing papers by Youlian Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youlian Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youlian Zhou. The network helps show where Youlian Zhou may publish in the future.

Co-authorship network of co-authors of Youlian Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Youlian Zhou. A scholar is included among the top collaborators of Youlian Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youlian Zhou. Youlian Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing, Jianhong Li, Chen-Tsung Huang, et al.. (2025). Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation. Advanced Science. 12(46). e09073–e09073.
2.
Li, Jianhong, Jing Xu, Jinxia Hu, et al.. (2025). PPARγ/β/δ Agonists Can Ameliorate Dextran Sodium Sulfate–Induced Colitis and Modulate Gut Microbiota. Journal of Gastroenterology and Hepatology. 40(6). 1536–1547. 3 indexed citations
3.
Xu, Jing, Haoming Xu, Xiang Li, et al.. (2025). Clostridium butyricum-induced balance in colonic retinol metabolism and short-chain fatty acid levels inhibit IgA-related mucosal immunity and relieve colitis developments. Microbiological Research. 298. 128203–128203. 3 indexed citations
4.
Xu, Jing, Haoming Xu, Jianhong Li, Youlian Zhou, & Yuqiang Nie. (2024). Sa1862 CLOSTRIDIUM BUTYRICUM GENERATED ANTI-INFLAMMATORY METABOLITES TO REGULATE MUCOSAL IMMUNITY RESPONSE TO GUT MICROBIOTA BY ACTIVATING RETINOL METABOLISM. Gastroenterology. 166(5). S–555.
5.
Liu, Chao, et al.. (2024). Metabolites of Microbiota: A Novel Therapy for Heart Disease. Food Reviews International. 41(4). 1099–1115. 1 indexed citations
6.
Huang, Chen, Youlian Zhou, Jiemin Cheng, et al.. (2023). Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy. Frontiers in Endocrinology. 14. 1145392–1145392. 17 indexed citations
7.
Guo, Xue, Jing Xu, Yan Zhang, et al.. (2023). Rapamycin extenuates experimental colitis by modulating the gut microbiota. Journal of Gastroenterology and Hepatology. 38(12). 2130–2141. 20 indexed citations
8.
Xu, Haoming, Xue Guo, Jiaqi Wang, et al.. (2023). IDDF2023-ABS-0100 Odoribacter. splanchnicus alleviate colitis by regulating neutrophil extracellular traps formation. A79–A81. 4 indexed citations
9.
Xu, Haoming, et al.. (2022). Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis. BMC Gastroenterology. 22(1). 117–117. 42 indexed citations
10.
He, Hanchang, Lu You, Dao Li, et al.. (2021). Gut Microbiota Profile in Adult Patients with Idiopathic Nephrotic Syndrome. BioMed Research International. 2021(1). 8854969–8854969. 35 indexed citations
11.
Xu, Haoming, Youlian Zhou, Youlian Zhou, et al.. (2021). Inhibition of PD‐1 Protects against TNBS‐Induced Colitis via Alteration of Enteric Microbiota. BioMed Research International. 2021(1). 4192451–4192451. 9 indexed citations
12.
Xu, Haoming, Hongli Huang, Jing Xu, et al.. (2021). Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation. Frontiers in Microbiology. 12. 658292–658292. 53 indexed citations
13.
Zhou, Yiling, Yuping Zeng, Si Wang, et al.. (2021). Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction. Frontiers in Pharmacology. 12. 770239–770239. 2 indexed citations
14.
Zhou, Youlian, Haoming Xu, Jing Xu, et al.. (2021). F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis. AMB Express. 11(1). 33–33. 67 indexed citations
15.
He, Hanchang, Haoming Xu, Jing Xu, et al.. (2020). Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice. Frontiers in Nutrition. 7. 604283–604283. 34 indexed citations
17.
Peng, Wei, et al.. (2020). Host Genetic and Environmental Factors Shape the Composition and Function of Gut Microbiota in Populations Living at High Altitude. BioMed Research International. 2020(1). 1482109–1482109. 25 indexed citations
18.
Zhou, Youlian, Zhenjiang Zech Xu, Yan He, et al.. (2018). Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems. 3(1). 247 indexed citations
19.
Zhou, Youlian, Huiting Chen, Hanchang He, et al.. (2016). Increased Enterococcus faecalis infection is associated with clinically active Crohn disease. Medicine. 95(39). e5019–e5019. 75 indexed citations
20.
Wang, Xianfei, Jing Li, Shiyong Lin, et al.. (2013). Low Molecular Weight Heparin Relieves Experimental Colitis in Mice by Downregulating IL-1β and Inhibiting Syndecan-1 Shedding in the Intestinal Mucosa. PLoS ONE. 8(7). e66397–e66397. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026